ArticleMedicine2026

Disproportionality analysis of sex-stratified adverse event signals in growth impairment: Insights from the FDA adverse event reporting system.

Xu Junyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.